Stockreport

Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF Access to protocol assistance, centralized authorization process, fee reductions and 10 years of market exclusivity SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics [Read more]